← All trials
NCT05915806
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 30, 2023
- Primary completion
- Sep 30, 2023
- Completion date
- Mar 31, 2024
- First posted
- Jun 23, 2023
- Last posted
- Sep 11, 2023
- Enrollment
- 1801
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Laval UniversityLead sponsor
- McGill UniversityCollaborator
- McGill UniversityOverall official - principal investigator
- McGill UniversityOverall official - principal investigator
- Laval UniversityCollaborator
- Laval UniversityOverall official - principal investigator
- Laval UniversityOverall official - principal investigator
- University of British ColumbiaOverall official - principal investigator
- South Australian Health and Medical Research InstituteCollaborator
- South Australian Health and Medical Research InstituteOverall official - principal investigator
- Canadian Institutes of Health Research (CIHR)Collaborator
- St. Justine's HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.